Radioactive iodine in thyroid medicine-How it started in Sweden and some of today's challenges

Author： Mattsson Sören   Johansson Lennart   Jönsson Helene   Nosslin Bertil  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.8, 2006-12, pp. : 1031-1036

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioactive iodine in thyroid medicine

By Rasmuson Torgny  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1011-1012

Informa Healthcare

Access to resources Recommend Favorite

Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer

By Nixon Iain J   Ganly Ian  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 921-923

Future Medicine

Access to resources Recommend Favorite

Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 692-698

Science Publishers

Access to resources Recommend Favorite

Thyroid cancer after exposure to radioactive 131I

By Holm Lars-Erik  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1037-1040

Informa Healthcare

Access to resources Recommend Favorite

Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine

By Rasmuson Torgny   Tavelin Björn  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1059-1061

Informa Healthcare

Access to resources Recommend Favorite